249 related articles for article (PubMed ID: 21459133)
41. Targeting human macrophages for enhanced killing of intracellular XDR-TB and MDR-TB.
Martins M; Viveiros M; Couto I; Amaral L
Int J Tuberc Lung Dis; 2009 May; 13(5):569-73. PubMed ID: 19383188
[TBL] [Abstract][Full Text] [Related]
42. Optimisation of the microplate resazurin assay for screening and bioassay-guided fractionation of phytochemical extracts against Mycobacterium tuberculosis.
O'Neill TE; Li H; Colquhoun CD; Johnson JA; Webster D; Gray CA
Phytochem Anal; 2014; 25(5):461-7. PubMed ID: 24733665
[TBL] [Abstract][Full Text] [Related]
43. Anti-tuberculosis drug resistance patterns and trends in a tuberculosis referral hospital, 1997-2009.
Liu CH; Li HM; Li L; Hu YL; Wang Q; Yang N; Wang S; Zhu B
Epidemiol Infect; 2011 Dec; 139(12):1909-18. PubMed ID: 21272420
[TBL] [Abstract][Full Text] [Related]
44. The resistance to major antituberculous drugs of Mycobacterium tuberculosis strains isolated from the respiratory system specimens of tuberculosis patients in Duzce, Turkey.
Ozturk CE; Balbay OA; Kaya D; Ceyhan I; Bulut I; Sahin I
Jpn J Infect Dis; 2005 Feb; 58(1):47-9. PubMed ID: 15728994
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of the flora of northern Mexico for in vitro antimicrobial and antituberculosis activity.
Molina-Salinas GM; Pérez-López A; Becerril-Montes P; Salazar-Aranda R; Said-Fernández S; de Torres NW
J Ethnopharmacol; 2007 Feb; 109(3):435-41. PubMed ID: 17000069
[TBL] [Abstract][Full Text] [Related]
46. Strain differentiation of Mycobacterium tuberculosis complex isolated from sputum of pulmonary tuberculosis patients.
Abbadi S; El Hadidy G; Gomaa N; Cooksey R
Int J Infect Dis; 2009 Mar; 13(2):236-42. PubMed ID: 18838283
[TBL] [Abstract][Full Text] [Related]
47. Risk factors for drug resistant tuberculosis in southeast Turkey.
Tanrikulu AC; Hosoglu S; Ozekinci T; Abakay A; Gurkan F
Trop Doct; 2008 Apr; 38(2):91-3. PubMed ID: 18453496
[TBL] [Abstract][Full Text] [Related]
48. Novel N-aryl- and N-heteryl phenazine-1-carboxamides as potential agents for the treatment of infections sustained by drug-resistant and multidrug-resistant Mycobacterium tuberculosis.
De Logu A; Palchykovska LH; Kostina VH; Sanna A; Meleddu R; Chisu L; Alexeeva IV; Shved AD
Int J Antimicrob Agents; 2009 Mar; 33(3):223-9. PubMed ID: 19070992
[TBL] [Abstract][Full Text] [Related]
49. Zanthoxylum capense constituents with antimycobacterial activity against Mycobacterium tuberculosis in vitro and ex vivo within human macrophages.
Luo X; Pires D; Aínsa JA; Gracia B; Duarte N; Mulhovo S; Anes E; Ferreira MJ
J Ethnopharmacol; 2013 Mar; 146(1):417-22. PubMed ID: 23337743
[TBL] [Abstract][Full Text] [Related]
50. Antimycobacterial activity of selected medicinal plants traditionally used in Sudan to treat infectious diseases.
Abuzeid N; Kalsum S; Koshy RJ; Larsson M; Glader M; Andersson H; Raffetseder J; Pienaar E; Eklund D; Alhassan MS; AlGadir HA; Koko WS; Schön T; Ahmed Mesaik M; Abdalla OM; Khalid A; Lerm M
J Ethnopharmacol; 2014 Nov; 157():134-9. PubMed ID: 25261689
[TBL] [Abstract][Full Text] [Related]
51. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ
Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154
[TBL] [Abstract][Full Text] [Related]
52. Study of the in vitro susceptibility of M. tuberculosis to ofloxacin in Spain. Spanish Study Group of M. tuberculosis resistance.
Casal M; Ruiz P; Herreras A
Int J Tuberc Lung Dis; 2000 Jun; 4(6):588-91. PubMed ID: 10864193
[TBL] [Abstract][Full Text] [Related]
53. Anti-mycobacterial Activity of 22 Iranian Endemic or Rare Plant Extracts Against Multi-drug and Extensively Drug-resistant
Dehestani S; Davoodi J; Emami SA; Seddighinia FS; Sahebkar A; Soleimanpour S
Comb Chem High Throughput Screen; 2022; 25(5):870-876. PubMed ID: 33588723
[TBL] [Abstract][Full Text] [Related]
54. A new rapid and simple colorimetric method to detect pyrazinamide resistance in Mycobacterium tuberculosis using nicotinamide.
Martin A; Takiff H; Vandamme P; Swings J; Palomino JC; Portaels F
J Antimicrob Chemother; 2006 Aug; 58(2):327-31. PubMed ID: 16751203
[TBL] [Abstract][Full Text] [Related]
55. Screening of terpenes and derivatives for antimycobacterial activity; identification of geranylgeraniol and geranylgeranyl acetate as potent inhibitors of Mycobacterium tuberculosis in vitro.
Vik A; James A; Gundersen LL
Planta Med; 2007 Oct; 73(13):1410-2. PubMed ID: 17924309
[TBL] [Abstract][Full Text] [Related]
56. [Fluctuation in the ratio between drug-resistant and -susceptible M. tuberculosis bacilli which were isolated from patients with prolonged anti-tuberculosis treatment].
Ano H; Matsumoto T; Yoshida H; Ishida C; Tanigawa N; Kawahara K; Toba H; Takashima T; Tsuyuguchi I
Kekkaku; 2003 Dec; 78(12):739-46. PubMed ID: 14733114
[TBL] [Abstract][Full Text] [Related]
57. Antituberculosis agents. VI. Activity of a new ciprofloxacin derivative against Mycobacterium avium and some drug-resistant strains of Mycobacterium tuberculosis.
Foroumadi A; Soltani F; Moshafi MH
Boll Chim Farm; 2002; 141(5):394-6. PubMed ID: 12481384
[TBL] [Abstract][Full Text] [Related]
58. Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995-2002, after the implementation of DOTS-plus.
Kam KM; Yip CW
Int J Tuberc Lung Dis; 2004 Jun; 8(6):760-6. PubMed ID: 15182147
[TBL] [Abstract][Full Text] [Related]
59. Detection of mutations associated with multidrug-resistant Mycobacterium tuberculosis clinical isolates.
Nimri L; Samara H; Batchoun R
FEMS Immunol Med Microbiol; 2011 Aug; 62(3):321-7. PubMed ID: 21569121
[TBL] [Abstract][Full Text] [Related]
60. [Study on the anti-carcinogenic effects of three compounds in Kaempferia galanga L].
Xue Y; Chen H
Wei Sheng Yan Jiu; 2002 Aug; 31(4):247-8, 251. PubMed ID: 12600030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
